The Marilyn and Stanley M. Katz Dean Albert Einstein College of Medicine of Yeshiva University
Highlights:
Appointed NIDDK Director November 1999 by NIH Director, Harold Varmus.
Transitioned from NIDDK/NIH in March 2006 to become Dean of Albert Einstein College of Medicine of Yeshiva University.
Served as member of NIH Stem Cell Task Force from creation in 2002 through 2005; Vice-Chair 2005-2006.
Conducted White House Oval Office briefing on stem cell research of former President George W. Bush, Karl Rove, and Andrew Card on August 2, 2001.
Testified before Senate and House in multiple hearings including several focused on stem cell research.
Allen M. Spiegel, M.D., an internationally recognized researcher and endocrinologist, assumed office as Dean of the Albert Einstein College of Medicine of Yeshiva University on June 1, 2006.
Prior to joining Einstein, Dr. Spiegel was Director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health, the culmination of a distinguished 33-year career at the NIH.
A member of the Institute of Medicine of the National Academy of Sciences, Dr. Spiegel earned his bachelor's degree summa cum laude and Phi Beta Kappa from Columbia University in 1967. He received his M.D. degree cum laude from Harvard Medical School in 1971 and completed his clinical training at Massachusetts General Hospital.
He began his career at the NIH in 1973 as a Clinical Associate in its Endocrinology Training program. He then served as a Senior Investigator in the Metabolic Disease Branch from 1977 to 1984. In 1985, he was appointed Chief of Molecular Pathophysiology, and then Chief of the Metabolic Diseases Branch. In 1990, he was appointed Director of the NIDDK's Division of Intramural Research. He served in these various capacities until his appointment as Director of the NIDDK in 1999. In this role, Dr. Spiegel had responsibility for a staff of 625 full-time employees and a $1.7 billion budget.
Dr. Spiegel is a widely renowned physician-scientist and endocrinologist with extensive experience in translational research programs. His research has centered on G-protein-regulated signaling dysfunction in human disease, and his work on signal transduction helped to clarify the genetic basis of several endocrine diseases. He has published extensively, with more than 250 peer-reviewed papers and 100 reviews and book chapters to his name, as well as two books on G proteins.
